Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoceptors

Journal of Neuroimmunology

Volumn 131, Issue 1-2, 2002, Pages 21-30

  Exton, Michael S ^a   Gierse, Claudia ^a   Meier, Bettina ^a   Mosen, Martin ^a   Xie, Yufen ^a   Frede, Stilla ^a   Goebel, Marion U ^a   Limmroth, Volker ^a   Schedlowski, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

6 OHDA; Adrenoceptors; Behavioral conditioning; IL 2; Propranolol

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MITOGENIC AGENT; NORADRENALIN; OXIDOPAMINE; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL FUNCTION; CHEMICAL SYMPATHECTOMY; CONDITIONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOMODULATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STIMULUS;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; CELL DIVISION; CELLS, CULTURED; IMMUNOSUPPRESSION; INTERFERON TYPE II; INTERLEUKIN-2; MALE; NEUROIMMUNOMODULATION; NOREPINEPHRINE; OXIDOPAMINE; PROPRANOLOL; RATS; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SPLEEN; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 0036789930     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00249-7     Document Type: Article

References (40)

1. Aarons R.D., Molinoff P.B. Changes in the density of β-adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J. Pharmacol. Exp. Ther. 221:1982;439-443.
2. Ader R., Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science. 215:1982;1534-1536.
3. Ader R., Cohen N. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 44:1992;53-85.
4. Ader R., Cohen N. Psychoneuroimmunology: conditioning and immunity. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. vol. 2:2001;3-34 Academic Press, San Diego.
5. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. 2001;Academic Press, San Diego.
6. Bartik M.M., Brooks W.H., Roszman T.L. Modulation of T-cell proliferation by stimulation of the β-adrenergic receptor: lack of correlation between inhibition of T-cell proliferation and cAMP accumulation. Cell. Immunol. 148:1993;408-421.
7. Bartik M.M., Bauman G.P., Brooks W.H., Roszman T.L. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell. Immunol. 158:1994;116-130.
8. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 10:1996;77-91.
9. Carlson S.L., Trauth K. Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells. J. Cell. Physiol. 161:1994;39-48.
10. Carlson S.L., Brooks W.H., Roszman T.L. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 24:1989;155-162.
11. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:2001;595-638.
12. Espinosa E., King M., Hill C., Bermudez-Rattoni F. Systemic propranolol does not disrupt, but alters conditioned enhancement of antibody production. Brain Behav. Immun. 14:2000;93-94.
13. Exton M.S., von Hörsten S., Schult M., Vöge J., Strubel T., Donath S., Nagel E., Westermann J., Schedlowski M. Behaviourally conditioned immunosuppression using cyclosporin A: CNS reduces IL-2 production via splenic innervation. J. Neuroimmunol. 88:1998;182-191.
14. Exton M.S., Schult M., Donath S., Strubel T., Bode U., del Rey A., Westermann J., Schedlowski M. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. 276:1999;R1710-R1717.
15. Exton M.S., von Auer A.K., Buske-Kirschbaum A., Stockhorst U., Gobel U., Schedlowski M. Pavlovian conditioning of immune function: animal investigation and the challenge of human application. Behav. Brain Res. 110:2000;129-141.
16. Exton M.S., Herklotz J., Westermann J., Schedlowski M. Conditioning in the rat: an in vivo model to investigate the molecular mechanisms and clinical implications of brain-immune communication. Immunol. Rev. 184:2001;226-235.
17. Felsner P., Hofer D., Rinner I., Mangge H., Gruber M., Korsatko W., Schauenstein K. Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lymphocytes via α-mediated mechanisms. J. Neuroimmunol. 57:1992;47-57.
18. 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71:1996;223-226.
19. +) cells. J. Neuroimmunol. 74:1997;159-164.
20. Kahan B.D. Cyclosporine. New Engl. J. Med. 321:1989;1725-1738.
21. Kammer G.M. The adenylate cyclase-cAMP-protein kinase: a pathway and regulation of the immune response. Immunol. Today. 9:1988;222-229.
22. Klonz A., Wonigeit K., Pabst R., Westermann J. The marginal blood pool of the rat contains not only granulocytes, but also lymphocytes, NK-cells, and monocytes: a second intravascular compartment, its cellular composition, adhesion molecule expression, and interaction with the peripheral blood pool. Scand. J. Immunol. 44:1996;461-469.
23. Klosterhalfen S., Klosterhalfen W. Conditioned cyclosporine effects, but not conditioned taste aversion in immunized rats. Behav. Neurosci. 104:1990;716-724.
24. Kohm A.P., Sanders V.M. Norepinephrine: a messenger from the brain to the immune system. Immunol. Today. 21:2000;539-542.
25. + T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53:2001;487-525.
26. Luecken L.J., Lysle D.T. Evidence for the involvement of β-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38:1992;209-219.
27. Lysle D.T., Cunnick J.E., Maslonek K.A. Pharmacological manipulation of immune alterations induced by an aversive conditioned stimulus: evidence for a β-adrenergic receptor-mediated Pavlovian conditioning process. Behav. Neurosci. 105:1991;443-449.
28. Madden K.S. Catecholamines, sympathetic nerves, and immunity. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. 2001;197-216 Academic Press, San Diego.
29. Maisel A.S., Fowler P., Rearden A., Motulsky H.J., Michel M.C. New method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46:1989;29-39.
30. Meier B.A., Goebel M.U., Gierse C., Exton M.S., Schedlowski M.S. Klassische Konditionierung von Immunfunktionen: Mechanismen und klinische Relevanz. Z. Med. Psychol. 11:2002;83-93.
31. + T cells exposed to norepinephrine. Brain Behav. Immun. 14:2000;239-255.
32. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the β-2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158:1997;4200-4210.
33. Sanders V.M., Kasprowicz D.J., Kohm A.P., Swanson M.A. Neurotransmitter receptors on lymphocytes and other lymphoid cells. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. vol. 1:2001;161-196 Academic Press, San Diego.
34. Schauenstein K., Felsner P., Rinner I., Liebmann P.M., Stevenson J.R., Westermann J., Haas H.S., Cohen R.L., Chambers D.A. In vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse models. Ann. N.Y. Acad. Sci. 917:2000;618-627.
35. Stevens-Felten S.Y., Bellinger D.L. Noradrenergic and peptidergic innervation of lymphoid organs. Chem. Immunol. 69:1997;99-131.
36. Stevenson J.R., Westermann J., Liebmann P.M., Hortner M., Rinner I., Felsner P., Wolfer A., Schauestein K. Prolonged α-adrenergic stimulation causes changes in leukocyte distribution and lymphocyte apoptosis in the rat. J. Neuroimmunol. 120:2001;50-57.
37. von Horsten S., Exton M.S., Schult M., Nagel E., Stalp M., Schweitzer G., Voge J., del Rey A., Schedlowski M., Westermann J. Behaviorally conditioned effects of cyclosporin A on the immune system of rats: specific alterations of blood leukocyte numbers and decrease of granulocyte function. J. Neuroimmunol. 85:1998;193-201.
38. Weihe E., Nohr D., Michel S., Muller S., Zentel H.J., Find T., Krekel J. Molecular anatomy of the neuroimmune connection. Int. J. Neurosci. 59:1991;1-23.
39. Westermann J., Pabst R. How organ-specific is the migration of "naive" and "memory" T cells? Immunol. Today. 17:1996;278-282.
40. Westermann J., Persin S., Matyas J., van der Meide P., Pabst R. Migration of so-called naive and memory T lymphocytes from blood to lymph in the rat. J. Immunol. 152:1994;1744-1749.